Market Overview:
The global upstream bioprocessing equipment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for biopharmaceuticals and rising investment in R&D by pharmaceutical and biotech companies. In terms of type, the continuous bioprocessing system segment is expected to dominate the market during the forecast period. This can be attributed to its ability to handle large-scale production and reduce process time as compared with single-use systems. By application, the pharmaceutical & biological manufacturing companies segment is expected to account for a major share of the global upstream bioprocessing equipment market during the forecast period.
Product Definition:
Upstream bioprocessing equipment refers to the machines and tools used in the early stages of manufacturing biological products such as vaccines or antibiotics. This equipment is important because it can affect the quality and purity of the final product.
Continuous Bioprocessing System:
Continuous Bioprocessing System (CBS) is a closed system that performs all the operations related to bioprocessing including sterile filtration, fluid transfer, mixing/temperature control and product recovery. It provides continuous production without any intermediate storage. The growth factor in the use of CBS includes its advantages such as it eliminates waste by recycling the spent media and reduces cost due to less requirement for consumables resulting in lower replacement cost.
Single-Use Bioprocessing System:
Single-Use Bioprocessing System is a closed system that contains all the components required to perform bioreactor operation. It includes media, reactor vessel, heat exchanger and air handling unit (AHE), filter press or filter sterilizer. SUS system eliminates the risk of contamination as it is completely sealed and hermetically sealed can be used for both small & large scale bioreactors.
Application Insights:
The pharmaceutical and biological manufacturing companies segment held the largest market share of over 40% in 2017. This is attributed to the increasing use of bioprocessing equipment for producing vaccines, therapeutic proteins, diagnostic reagents and other products. The growing importance of these products in terms of revenue generation cannot be underestimated. For instance, according to a study published by the World Health Organization (WHO) in 2018, it was estimated that around 1 billion people do not have access to any form of immunization against diseases such as measles, whooping cough or chickenpox.
In addition, there are various initiatives taken by governments across the world for ensuring immunization coverage against major diseases among children below 5 years old including DTP3 vaccine coverage through routine Immunization Days which is an initiative undertaken by WHO with support from national governments and partners working with them globally since 2013-14 till date.
Regional Analysis:
North America dominated the global market in 2017. The growth of this region can be attributed to the presence of a large number of pharmaceutical and biotechnology companies, which are engaged in drug discovery and development processes. These companies are focusing on reducing costs associated with drug discovery process by adopting UBEs at their upstream facilities. Moreover, increasing investments by these companies for improving productivity is expected to drive regional demand over the forecast period.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to factors such as favorable government initiatives pertaining to R&D investment along with rising healthcare expenditure in countries such as China and India that has led them being referred as emerging economies or BRIC nations (Brazil, Russia, India & China). Furthermore, growing awareness regarding advanced technologies among research organizations operating within this region will propel regional demand during the forecast years.
Growth Factors:
- Increasing demand for biopharmaceuticals: The global biopharmaceutical market is expected to grow at a CAGR of 10.5% from 2016 to 2021, reaching a value of 2.8 billion by 2021. This growth is primarily attributed to the increasing prevalence of chronic diseases, rising awareness about preventive healthcare, and technological advancements in the field of biotechnology.
- Growing investment in R&D: Pharmaceutical and biotech companies are investing heavily in R&D to develop novel therapies and expand their product portfolios. For instance, according to Ernst & Young’s 2017 Global Biotech Report, the top 10 biotech companies invested a total of .8 billion in R&D in 2016, up from billion in 2015. This is expected to drive the demand for upstream processing equipment over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Upstream Bioprocessing Equipment Market Research Report
By Type
Continuous Bioprocessing System, Single-Use Bioprocessing System
By Application
Pharmaceutical & Biological Manufacturing Companies, Research Centers
By Companies
GE Healthcare, Merck, Thermo Fisher Scientific, Boehringer Ingelheim Pharma GmbH & Co.KG,, BiOZEEN, Katalyst Bio Engineering, ABEC Biopharmaceutical Manufacturing, Bionet Engineering, Lonza- Pharma & Biotech, Corning
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Upstream Bioprocessing Equipment Market Report Segments:
The global Upstream Bioprocessing Equipment market is segmented on the basis of:
Types
Continuous Bioprocessing System, Single-Use Bioprocessing System
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical & Biological Manufacturing Companies, Research Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE Healthcare
- Merck
- Thermo Fisher Scientific
- Boehringer Ingelheim Pharma GmbH & Co.KG,
- BiOZEEN
- Katalyst Bio Engineering
- ABEC Biopharmaceutical Manufacturing
- Bionet Engineering
- Lonza- Pharma & Biotech
- Corning
Highlights of The Upstream Bioprocessing Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Continuous Bioprocessing System
- Single-Use Bioprocessing System
- By Application:
- Pharmaceutical & Biological Manufacturing Companies
- Research Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Upstream Bioprocessing Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Upstream bioprocessing equipment is used to process biological materials upstream of the final product. This includes everything from harvesting and culturing cells, to extracting and purifying proteins or other molecules.
Some of the key players operating in the upstream bioprocessing equipment market are GE Healthcare, Merck, Thermo Fisher Scientific, Boehringer Ingelheim Pharma GmbH & Co.KG,, BiOZEEN, Katalyst Bio Engineering, ABEC Biopharmaceutical Manufacturing, Bionet Engineering, Lonza- Pharma & Biotech, Corning.
The upstream bioprocessing equipment market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Upstream Bioprocessing Equipment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Upstream Bioprocessing Equipment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Upstream Bioprocessing Equipment Market - Supply Chain
4.5. Global Upstream Bioprocessing Equipment Market Forecast
4.5.1. Upstream Bioprocessing Equipment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Upstream Bioprocessing Equipment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Upstream Bioprocessing Equipment Market Absolute $ Opportunity
5. Global Upstream Bioprocessing Equipment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Upstream Bioprocessing Equipment Market Size and Volume Forecast by Type
5.3.1. Continuous Bioprocessing System
5.3.2. Single-Use Bioprocessing System
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Upstream Bioprocessing Equipment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Upstream Bioprocessing Equipment Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical & Biological Manufacturing Companies
6.3.2. Research Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Upstream Bioprocessing Equipment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Upstream Bioprocessing Equipment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Upstream Bioprocessing Equipment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Upstream Bioprocessing Equipment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Upstream Bioprocessing Equipment Demand Share Forecast, 2019-2026
9. North America Upstream Bioprocessing Equipment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Upstream Bioprocessing Equipment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Upstream Bioprocessing Equipment Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical & Biological Manufacturing Companies
9.4.2. Research Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Upstream Bioprocessing Equipment Market Size and Volume Forecast by Type
9.7.1. Continuous Bioprocessing System
9.7.2. Single-Use Bioprocessing System
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Upstream Bioprocessing Equipment Demand Share Forecast, 2019-2026
10. Latin America Upstream Bioprocessing Equipment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Upstream Bioprocessing Equipment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Upstream Bioprocessing Equipment Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical & Biological Manufacturing Companies
10.4.2. Research Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Upstream Bioprocessing Equipment Market Size and Volume Forecast by Type
10.7.1. Continuous Bioprocessing System
10.7.2. Single-Use Bioprocessing System
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Upstream Bioprocessing Equipment Demand Share Forecast, 2019-2026
11. Europe Upstream Bioprocessing Equipment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Upstream Bioprocessing Equipment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Upstream Bioprocessing Equipment Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical & Biological Manufacturing Companies
11.4.2. Research Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Upstream Bioprocessing Equipment Market Size and Volume Forecast by Type
11.7.1. Continuous Bioprocessing System
11.7.2. Single-Use Bioprocessing System
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Upstream Bioprocessing Equipment Demand Share, 2019-2026
12. Asia Pacific Upstream Bioprocessing Equipment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Upstream Bioprocessing Equipment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Upstream Bioprocessing Equipment Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical & Biological Manufacturing Companies
12.4.2. Research Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Upstream Bioprocessing Equipment Market Size and Volume Forecast by Type
12.7.1. Continuous Bioprocessing System
12.7.2. Single-Use Bioprocessing System
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Upstream Bioprocessing Equipment Demand Share, 2019-2026
13. Middle East & Africa Upstream Bioprocessing Equipment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Upstream Bioprocessing Equipment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Upstream Bioprocessing Equipment Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical & Biological Manufacturing Companies
13.4.2. Research Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Upstream Bioprocessing Equipment Market Size and Volume Forecast by Type
13.7.1. Continuous Bioprocessing System
13.7.2. Single-Use Bioprocessing System
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Upstream Bioprocessing Equipment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Upstream Bioprocessing Equipment Market: Market Share Analysis
14.2. Upstream Bioprocessing Equipment Distributors and Customers
14.3. Upstream Bioprocessing Equipment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE Healthcare
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Thermo Fisher Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boehringer Ingelheim Pharma GmbH & Co.KG,
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BiOZEEN
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Katalyst Bio Engineering
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. ABEC Biopharmaceutical Manufacturing
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bionet Engineering
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Lonza- Pharma & Biotech
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Corning
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
